C27Pre-exposure prophylaxis (PrEP) use among MSM in Brazil is associated with greater HIV knowledge and lower internalized homonegativityE-posterPrEP
C27Predictors of no PrEP or condom use among MSM in West Africa (CohMSM-PrEP ANRS12369 ' Expertise France)E-posterPrEP
B21Prediction of coronary artery disease in high-risk people living with HIV in AsiaE-posterCardiovascular disease
B18Poor sleep quality in people with HIV linked to lower amyloid beta 42 levels in cerebrospinal fluidE-posterNeurologic disorders
D28Poor COVID-19 vaccination uptake in a cohort of Clinically Extremely Vulnerable (CEV) people living with HIV: a sign of the challenge ahead?E-posterIntegration of prevention interventions with care/treatment
D86Poor concordance between objective and reported measures of pre-exposure prophylaxis (PrEP) adherence and factors associated with over-reported adherence among adolescent girls and young women (AGYW) in KenyaE-posterAdolescent girls and young women
D42Policy changes to prevention, diagnosis and treatment to HIV during COVID-19 pandemicE-posterChanges in policy and practice
D15Policy changes in Honduras to ensure access to treatment in the context of COVID-19 and two hurricanesE-posterRetention in HIV services
B8Plasma separation cards are suitable for HIV-1 genotypic drug resistance testingOn-demand oral abstract sessionDrug resistance testing
B58Plasma IP-10 concentrations show no correlation with HIV infection in children attending hospitals in Blantyre and Mulanje, MalawiE-posterDiagnosis of HIV disease in paediatric and adolescent populations
261 - 270 of 870 items